Manufacturing and distribution of pharmaceutical products across various health categories.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Solitaire Pharmaceuticals

Solitaire Pharmaceuticals is a company. Solitaire Pharmaceuticals offers products and services including ETOCLAV-300 and LEZOTIME-600.

  • Sectors
    Healthcare
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Solitaire Pharmaceuticals
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Solitaire Pharmaceuticals

Solitaire Pharmaceuticals offers a comprehensive portfolio of products and services, including ETOCLAV-300 and LEZOTIME-600.

Product name locked
Category locked
Primary

This product is manufactured for use in treating bacterial infections.

Product name locked
Category locked
Locked

It is produced for addressing parasitic conditions in patients.

Funding Insights of Solitaire Pharmaceuticals

Premium access

Detailed funding history for Solitaire Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solitaire Pharmaceuticals

Investments
Premium access

Investment portfolio details for Solitaire Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Solitaire Pharmaceuticals

Premium access

Detailed financials for Solitaire Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Solitaire Pharmaceuticals Comparisons

Solitaire Pharmaceuticals Primary company
Description
Manufacturing and distribution of pharmaceutical products ac...
Location
-
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Solitaire Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Solitaire Pharmaceuticals

Premium access

Detailed competitors of Solitaire Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Solitaire Pharmaceuticals

Premium access

Complete news archive for Solitaire Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solitaire Pharmaceuticals

Solitaire Pharmaceuticals is recognized for its involvement in producing and supplying a range of pharmaceutical items, including antibiotics, antihelmintics, and nutritional supplements. Products such as ETOCLAV-300 and LEZOTIME-600 are listed under categories like gynecology and gastroenterology, with details available for reference. Contact is facilitated through specified phone numbers, and customer satisfaction is addressed via FAQs and policies. The companys offerings cover multiple therapeutic areas, ensuring essential medications are provided to meet health needs.

Solitaire Pharmaceuticals offers ETOCLAV-300 and LEZOTIME-600.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available